EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real or fake? Sourcing and marketing of non‐prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia

Jodie Grigg iD, Amy Peacock iD, Simon Lenton iD, Caroline Salom, Seraina Agramunt, Natalie Thomas iD, Tom Lyons, Rachel Sutherland iD

Drug and Alcohol Review · 2023

DOI: 10.1111/dar.13722 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Review, 2023. Verfasst von Jodie Grigg und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Drug Research Institute and enAble Institute, Curtin University, Perth, Australia. Hauptthemen laut MEDLINE: Benzodiazepines, Controlled Substances, Counterfeit Drugs, Illicit Drugs. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Department of Health and Aged Care, Australian Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

There is concern around non‐prescribed benzodiazepine use, particularly with increasing detections of counterfeit products containing high‐risk novel compounds. The aims of this study were to investigate how and which non‐prescribed benzodiazepines are being sourced; forms, appearance and packaging; and awareness of risks associated with non‐prescribed benzodiazepines.

Methods

Data were collected from a sample of Australians who inject drugs or use ecstasy and/or other illicit stimulants on a monthly or more frequent basis, and who reported past 6‐month use of non‐prescribed benzodiazepines ( n = 235 and n = 250, respectively). Data were collected on source, diversion from a known/trusted prescription, product name and aesthetic characteristics for the last non‐prescribed benzodiazepine obtained.

Results

Amongst participants who injected drugs, 71% reported that their last non‐prescribed benzodiazepines were diverted from a known/trusted prescription, compared to 59% of participants who used ecstasy/other stimulants. Sourcing via cryptomarkets was rare. Across both samples, the majority reported last obtaining substances sold/marketed as diazepam or alprazolam. Participants sourcing via non‐diverted means were twice as likely to obtain alprazolam. Known sourcing of novel compounds was rare. Amongst participants who used ecstasy/other stimulants, 36% reported confidence in the content/dose of non‐prescribed benzodiazepines even when the source is unknown. Discussion and Conclusions Most participants obtained substances sold as classic/registered benzodiazepines, mostly via diverted prescriptions, with a substantial minority potentially unaware of counterfeits circulating. While diverted use undeniably presents risks, tightening of prescriptions in Australia could inadvertently lead to greater supply of novel benzodiazepines as seen internationally, reinforcing prioritisation of demand and harm reduction strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesControlled SubstancesCounterfeit DrugsIllicit DrugsMarketingPatient HarmPatient Medication KnowledgeAdultFemaleHumansMaleMiddle AgedYoung AdultAlprazolamAustraliaChemical SafetyConsumer Product SafetyDiazepamDrug MisuseDrug PackagingDrugs, GenericInterviews as TopicN-Methyl-3,4-methylenedioxyamphetaminePrescription Drug Monitoring ProgramsRiskSelf ReportUncertainty

Stichwörter der Autor:innen

benzodiazepinecounterfeit medicinescryptomarketsdiversionnew psychoactive substances

Substanzen

AlprazolamBenzodiazepinesControlled SubstancesCounterfeit DrugsDiazepamDrugs, GenericIllicit DrugsN-Methyl-3,4-methylenedioxyamphetamine

Autor:innen und Institutionen

  • National Drug Research Institute and enAble Institute, Curtin University, Perth, Australia.
  • National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia.
  • School of Psychology, University of Tasmania, Hobart, Australia.
  • Institute for Social Science Research, University of Queensland, Brisbane, Australia.
  • Mental Health and Wellbeing Division, Department of Health, Melbourne, Victoria, Australia.

ORCID-Profile: Jodie Grigg, Amy Peacock, Simon Lenton, Natalie Thomas, Rachel Sutherland

Förderung

  • Department of Health and Aged Care, Australian Government

Zitieren

APA

Grigg, J., Peacock, A., Lenton, S., Salom, C., Agramunt, S., Thomas, N., Lyons, T., & Sutherland, R. (2023). Real or fake? Sourcing and marketing of non‐prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia. Drug and Alcohol Review. https://doi.org/10.1111/dar.13722

Vancouver

Grigg J, Peacock A, Lenton S, Salom C, Agramunt S, Thomas N, et al. Real or fake? Sourcing and marketing of non‐prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia. Drug and Alcohol Review. 2023. doi:10.1111/dar.13722

BibTeX
@article{Grigg2023,
  author = {Grigg, Jodie and Peacock, Amy and Lenton, Simon and Salom, Caroline and Agramunt, Seraina and Thomas, Natalie and Lyons, Tom and Sutherland, Rachel},
  title = {Real or fake? Sourcing and marketing of non‐prescribed benzodiazepines amongst two samples of people who regularly use illicit drugs in Australia},
  journal = {Drug and Alcohol Review},
  year = {2023},
  doi = {10.1111/dar.13722}
}
Kostenlos starten →